GenovaGENOVA,Inc.9341東証プライムサービス業FY ending Mar 2026, consolidated, J-GAAP

Genova FY ending Mar 2022 results

About 60% of Genova's sales come from Medical platform business, with Smart clinic business and Other making up much of the rest.

Out of every ¥100 of sales, about ¥22 is left as operating profit.

Where the money goes

Where ¥100 of sales goes

For every ¥100 Genova sells, how much goes where, and how much is kept.

FY ending Mar 2022
Cost of sales
¥27
SG&A
¥51
Operating profit
¥22
Net profit kept
¥14

Margin funnel (derived from reported values)Gross margin 72.8% → Operating margin 22.0% → Net margin 14.3%

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Mar 2022
  • Medical platform business¥2.9B
    60%
    Op. margin 50.1%
  • Smart clinic business¥1.25B
    26%
    Op. margin 23.8%
  • Other¥652.9M
    14%
    Op. margin 35.4%Industry: Health Tech

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (3)
  • EDINET (FSA Japan)

    有価証券報告書-第21期(2025/04/01-2026/03/31)

    ID S100YFQH2026-06-22Open
  • EDINET (FSA Japan)

    有価証券報告書-第19期(2023/04/01-2024/03/31)

    ID S100TR242024-06-24Open
  • EDINET (FSA Japan)

    有価証券報告書-第18期(2022/04/01-2023/03/31)

    ID S100R2ZE2023-06-23Open

Extracted from XBRL: 40 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.